Heart transplant clinical trial expands access to lifesaving medicine is drawing significant interest across the industry.
Xvivo Perfusion's clinical trial for a new heart transplant technology will soon be reviewed by the FDA. It helped one patient live.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →